News

AUSTIN, Texas — A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published today in the American Stroke Association’s journal Stroke. The study was led by a team of neurologists… read more 

UT researchers created an electrode that can be used to rehabilitate stroke patients at home, according to a study published online in Biosensors and Bioelectronics on Sept. 28. Evan Wang, one of the principal investigators, said the electrode consists of a three-dimensional interface, which results in a higher quality recording… read more 

Researchers from UT, Baylor University and the University of Missouri identified increased use of internet-enabled behaviors in older adults during the pandemic, according to a study published in Work, Aging and Retirement on Aug. 6. An internet-enabled behavior, or IEB, is an activity made possible by the internet, such as… read more 

Since launching in 2014, Dell Medical School at The University of Texas at Austin has been rethinking the role of academic medicine in improving health, particularly for those most in need. And we’re just getting started. Nominated and selected by their peer leaders, Dell Med’s Visionaries are on a mission… read more 

For many years, the study of focal brain lesions has played an important role in our effort to localize specific neurological functions to precise anatomic brain regions. Because of the acute onset and distinct anatomical localization of ischemic brain infarction, functional correlation studies have relied heavily on individuals with stroke.… read more